SARS-CoV-2 infection-induced activation of microglia may increase the expression of TNF-α, IL-6, IL-1β, nitric oxide, and chemokine C–C motif ligand 2, which may further increase the AD-related tau pathology [183, 184]. The gene discussed is MAPT; the disease is Alzheimer disease.